Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch

Patrick L. Mulcrone, J. Preston Campbell, Lise Clément-Demange, Ana Lia Anbinder, Alyssa R. Merkel, Rolf A. Brekken, Julie A. Sterling, Florent Elefteriou

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

The skeleton is a common site for breast cancer metastasis. Although significant progress has been made to manage osteolytic bone lesions, the mechanisms driving the early steps of the bone metastatic process are still not sufficiently understood to design efficacious strategies needed to inhibit this process and offer preventative therapeutic options. Progression and recurrence of breast cancer, as well as reduced survival of patients with breast cancer, are associated with chronic stress, a condition known to stimulate sympathetic nerve outflow. In this study, we show that stimulation of the beta 2-adrenergic receptor (β2AR) by isoproterenol, used as a pharmacological surrogate of sympathetic nerve activation, led to increased blood vessel density and Vegf-a expression in bone. It also raised levels of secreted Vegf-a in osteoblast cultures, and accordingly, the conditioned media from isoproterenol-treated osteoblast cultures promoted new vessel formation in two ex vivo models of angiogenesis. Blocking the interaction between Vegf-a and its receptor, Vegfr2, blunted the increase in vessel density induced by isoproterenol. Genetic loss of the β2AR globally, or specifically in type 1 collagen-expressing osteoblasts, diminished the increase in Vegf-positive osteoblast number and bone vessel density induced by isoproterenol, and reduced the higher incidence of bone metastatic lesions induced by isoproterenol after intracardiac injection of an osteotropic variant of MDA-MB-231 breast cancer cells. Inhibition of the interaction between Vegf-a and Vegfr2 with the blocking antibody mcr84 also prevented the increase in bone vascular density and bone metastasis triggered by isoproterenol. Together, these results indicate that stimulation of the β2AR in osteoblasts triggers a Vegf-dependent neo-angiogenic switch that promotes bone vascular density and the colonization of the bone microenvironment by metastatic breast cancer cells.

Original languageEnglish (US)
Pages (from-to)1442-1454
Number of pages13
JournalJournal of Bone and Mineral Research
Volume32
Issue number7
DOIs
StatePublished - Jul 1 2017

Fingerprint

Osteoblasts
Isoproterenol
Adrenergic Receptors
Vascular Endothelial Growth Factor A
Breast Neoplasms
Bone and Bones
Bone Density
Blood Vessels
Adrenergic beta-2 Receptors
Neoplasm Metastasis
Blocking Antibodies
Conditioned Culture Medium
Collagen Type I
Skeleton
Pharmacology
Recurrence
Injections
Survival
Incidence

Keywords

  • BONE VASCULATURE
  • BREAST CANCER
  • OSTEOBLAST
  • VEGF
  • β2AR

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Orthopedics and Sports Medicine

Cite this

Mulcrone, P. L., Campbell, J. P., Clément-Demange, L., Anbinder, A. L., Merkel, A. R., Brekken, R. A., ... Elefteriou, F. (2017). Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch. Journal of Bone and Mineral Research, 32(7), 1442-1454. https://doi.org/10.1002/jbmr.3133

Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch. / Mulcrone, Patrick L.; Campbell, J. Preston; Clément-Demange, Lise; Anbinder, Ana Lia; Merkel, Alyssa R.; Brekken, Rolf A.; Sterling, Julie A.; Elefteriou, Florent.

In: Journal of Bone and Mineral Research, Vol. 32, No. 7, 01.07.2017, p. 1442-1454.

Research output: Contribution to journalArticle

Mulcrone, PL, Campbell, JP, Clément-Demange, L, Anbinder, AL, Merkel, AR, Brekken, RA, Sterling, JA & Elefteriou, F 2017, 'Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch', Journal of Bone and Mineral Research, vol. 32, no. 7, pp. 1442-1454. https://doi.org/10.1002/jbmr.3133
Mulcrone, Patrick L. ; Campbell, J. Preston ; Clément-Demange, Lise ; Anbinder, Ana Lia ; Merkel, Alyssa R. ; Brekken, Rolf A. ; Sterling, Julie A. ; Elefteriou, Florent. / Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch. In: Journal of Bone and Mineral Research. 2017 ; Vol. 32, No. 7. pp. 1442-1454.
@article{9d19910cc798448e873af942993b6e32,
title = "Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch",
abstract = "The skeleton is a common site for breast cancer metastasis. Although significant progress has been made to manage osteolytic bone lesions, the mechanisms driving the early steps of the bone metastatic process are still not sufficiently understood to design efficacious strategies needed to inhibit this process and offer preventative therapeutic options. Progression and recurrence of breast cancer, as well as reduced survival of patients with breast cancer, are associated with chronic stress, a condition known to stimulate sympathetic nerve outflow. In this study, we show that stimulation of the beta 2-adrenergic receptor (β2AR) by isoproterenol, used as a pharmacological surrogate of sympathetic nerve activation, led to increased blood vessel density and Vegf-a expression in bone. It also raised levels of secreted Vegf-a in osteoblast cultures, and accordingly, the conditioned media from isoproterenol-treated osteoblast cultures promoted new vessel formation in two ex vivo models of angiogenesis. Blocking the interaction between Vegf-a and its receptor, Vegfr2, blunted the increase in vessel density induced by isoproterenol. Genetic loss of the β2AR globally, or specifically in type 1 collagen-expressing osteoblasts, diminished the increase in Vegf-positive osteoblast number and bone vessel density induced by isoproterenol, and reduced the higher incidence of bone metastatic lesions induced by isoproterenol after intracardiac injection of an osteotropic variant of MDA-MB-231 breast cancer cells. Inhibition of the interaction between Vegf-a and Vegfr2 with the blocking antibody mcr84 also prevented the increase in bone vascular density and bone metastasis triggered by isoproterenol. Together, these results indicate that stimulation of the β2AR in osteoblasts triggers a Vegf-dependent neo-angiogenic switch that promotes bone vascular density and the colonization of the bone microenvironment by metastatic breast cancer cells.",
keywords = "BONE VASCULATURE, BREAST CANCER, OSTEOBLAST, VEGF, β2AR",
author = "Mulcrone, {Patrick L.} and Campbell, {J. Preston} and Lise Cl{\'e}ment-Demange and Anbinder, {Ana Lia} and Merkel, {Alyssa R.} and Brekken, {Rolf A.} and Sterling, {Julie A.} and Florent Elefteriou",
year = "2017",
month = "7",
day = "1",
doi = "10.1002/jbmr.3133",
language = "English (US)",
volume = "32",
pages = "1442--1454",
journal = "Journal of Bone and Mineral Research",
issn = "0884-0431",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch

AU - Mulcrone, Patrick L.

AU - Campbell, J. Preston

AU - Clément-Demange, Lise

AU - Anbinder, Ana Lia

AU - Merkel, Alyssa R.

AU - Brekken, Rolf A.

AU - Sterling, Julie A.

AU - Elefteriou, Florent

PY - 2017/7/1

Y1 - 2017/7/1

N2 - The skeleton is a common site for breast cancer metastasis. Although significant progress has been made to manage osteolytic bone lesions, the mechanisms driving the early steps of the bone metastatic process are still not sufficiently understood to design efficacious strategies needed to inhibit this process and offer preventative therapeutic options. Progression and recurrence of breast cancer, as well as reduced survival of patients with breast cancer, are associated with chronic stress, a condition known to stimulate sympathetic nerve outflow. In this study, we show that stimulation of the beta 2-adrenergic receptor (β2AR) by isoproterenol, used as a pharmacological surrogate of sympathetic nerve activation, led to increased blood vessel density and Vegf-a expression in bone. It also raised levels of secreted Vegf-a in osteoblast cultures, and accordingly, the conditioned media from isoproterenol-treated osteoblast cultures promoted new vessel formation in two ex vivo models of angiogenesis. Blocking the interaction between Vegf-a and its receptor, Vegfr2, blunted the increase in vessel density induced by isoproterenol. Genetic loss of the β2AR globally, or specifically in type 1 collagen-expressing osteoblasts, diminished the increase in Vegf-positive osteoblast number and bone vessel density induced by isoproterenol, and reduced the higher incidence of bone metastatic lesions induced by isoproterenol after intracardiac injection of an osteotropic variant of MDA-MB-231 breast cancer cells. Inhibition of the interaction between Vegf-a and Vegfr2 with the blocking antibody mcr84 also prevented the increase in bone vascular density and bone metastasis triggered by isoproterenol. Together, these results indicate that stimulation of the β2AR in osteoblasts triggers a Vegf-dependent neo-angiogenic switch that promotes bone vascular density and the colonization of the bone microenvironment by metastatic breast cancer cells.

AB - The skeleton is a common site for breast cancer metastasis. Although significant progress has been made to manage osteolytic bone lesions, the mechanisms driving the early steps of the bone metastatic process are still not sufficiently understood to design efficacious strategies needed to inhibit this process and offer preventative therapeutic options. Progression and recurrence of breast cancer, as well as reduced survival of patients with breast cancer, are associated with chronic stress, a condition known to stimulate sympathetic nerve outflow. In this study, we show that stimulation of the beta 2-adrenergic receptor (β2AR) by isoproterenol, used as a pharmacological surrogate of sympathetic nerve activation, led to increased blood vessel density and Vegf-a expression in bone. It also raised levels of secreted Vegf-a in osteoblast cultures, and accordingly, the conditioned media from isoproterenol-treated osteoblast cultures promoted new vessel formation in two ex vivo models of angiogenesis. Blocking the interaction between Vegf-a and its receptor, Vegfr2, blunted the increase in vessel density induced by isoproterenol. Genetic loss of the β2AR globally, or specifically in type 1 collagen-expressing osteoblasts, diminished the increase in Vegf-positive osteoblast number and bone vessel density induced by isoproterenol, and reduced the higher incidence of bone metastatic lesions induced by isoproterenol after intracardiac injection of an osteotropic variant of MDA-MB-231 breast cancer cells. Inhibition of the interaction between Vegf-a and Vegfr2 with the blocking antibody mcr84 also prevented the increase in bone vascular density and bone metastasis triggered by isoproterenol. Together, these results indicate that stimulation of the β2AR in osteoblasts triggers a Vegf-dependent neo-angiogenic switch that promotes bone vascular density and the colonization of the bone microenvironment by metastatic breast cancer cells.

KW - BONE VASCULATURE

KW - BREAST CANCER

KW - OSTEOBLAST

KW - VEGF

KW - β2AR

UR - http://www.scopus.com/inward/record.url?scp=85018255202&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018255202&partnerID=8YFLogxK

U2 - 10.1002/jbmr.3133

DO - 10.1002/jbmr.3133

M3 - Article

VL - 32

SP - 1442

EP - 1454

JO - Journal of Bone and Mineral Research

JF - Journal of Bone and Mineral Research

SN - 0884-0431

IS - 7

ER -